Full Text View
Tabular View
No Study Results Posted
Related Studies
Impact of Chlorhexidine Cleansing on Bacteria Colonizing the Umbilical Cord of Infants in Bangladesh
This study is currently recruiting participants.
Verified by Johns Hopkins Bloomberg School of Public Health, January 2009
First Received: July 17, 2008   Last Updated: January 27, 2009   History of Changes
Sponsors and Collaborators: Johns Hopkins Bloomberg School of Public Health
Dhaka Shishu Hospital
Shimantik, Bangladesh
Thrasher Research Fund
Information provided by: Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov Identifier: NCT00719329
  Purpose

Background: In developing countries, many babies are born at home and the umbilical cord commonly becomes infected during the first week after birth, and can be deadly. Cleansing of the cord with a low-cost antiseptic like chlorhexidine may reduce the risk of these infections. Little is known, however, about the frequency of chlorhexidine cleansing needed to impact upon the overall presence of bacteria on the stump, or regarding the changes in bacteria during the first week of life when most cord infections occur.

Objectives: We will describe the profile of bacteria colonizing the umbilical cord stump of infants in rural Bangladesh and examine the role of topical chlorhexidine in altering colonization and progress of infection. We will compare the overall and bacteria-specific rate of colonization of the cord stump between infants receiving chlorhexidine cleansing of their cord through the first day or first week of life. We will also quantify the relationship between colonization of the cord stump with specific pathogens and the presence and severity of signs of umbilical cord infection (pus, redness, swelling) among these newborns.

Potential Impact: More information is needed on the impact of single versus repeated applications of chlorhexidine to the cord stump, as the number of cleansing may substantially influence the feasibility of widespread scale-up in many populations. The data generated from this proposed study will guide the most appropriate design of this simple intervention and will help inform specific treatment protocols for effective management of infants with signs of umbilical cord infections.


Condition Intervention
Infection
Neonates
Drug: Chlorhexidine 4.0%
Behavioral: Dry Cord Care

Drug Information available for: Chlorhexidine Chlorhexidine digluconate Hibiclens
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title: Bacterial Colonization of the Neonatal Umbilical Cord and Impact of 4.0% Chlorhexidine Cleansing on the Bacteriological Profile of the Umbilical Cord of Newborns in Sylhet District, Bangladesh

Further study details as provided by Johns Hopkins Bloomberg School of Public Health:

Primary Outcome Measures:
  • Bacteriological profile of the umbilical cord [ Time Frame: First week of life ] [ Designated as safety issue: No ]

Estimated Enrollment: 1800
Study Start Date: August 2008
Estimated Study Completion Date: September 2009
Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
A: Experimental
Chlorhexidine cleansing of the cord for seven days
Drug: Chlorhexidine 4.0%
Solution (4.0%, 7.1% CHX-D)
B: Experimental
Chlorhexidine cleansing of the cord for 1 day
Drug: Chlorhexidine 4.0%
Solution (4.0%, 7.1% CHX-D)
C: Placebo Comparator
Dry cord care, as recommended by WHO
Behavioral: Dry Cord Care
Educational messages regarding clean cord care

  Eligibility

Ages Eligible for Study:   up to 7 Days
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Enrolled in parent chlorhexidine cleansing trial

Exclusion Criteria:

  • Not enrolled in parent trial
  • First visited after 48 hours of life
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00719329

Contacts
Contact: Luke C Mullany, PhD 410-502-2626 lmullany@jhsph.edu

Locations
United States, Maryland
Johns Hopkins Bloomberg School of Public Health Not yet recruiting
Baltimore, Maryland, United States, 21205
Principal Investigator: Luke C Mullany, PhD            
Bangladesh
Dhaka Shishu Hospital Recruiting
Dhaka, Bangladesh
Principal Investigator: Samir K Saha            
Bangladesh, Sylhet
Projahnmo Recruiting
Sylhet City, Sylhet, Bangladesh
Sponsors and Collaborators
Johns Hopkins Bloomberg School of Public Health
Dhaka Shishu Hospital
Shimantik, Bangladesh
Thrasher Research Fund
Investigators
Study Director: Luke C Mullany, PhD Johns Hopkins School of Public Health
  More Information

No publications provided

Responsible Party: Johns Hopkins Bloomberg School of Public Health ( Luke C. Mullany, Assistant Professor )
Study ID Numbers: THRASHER-02827-0
Study First Received: July 17, 2008
Last Updated: January 27, 2009
ClinicalTrials.gov Identifier: NCT00719329     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Johns Hopkins Bloomberg School of Public Health:
chlorhexidine
umbilical cord

Study placed in the following topic categories:
Anti-Infective Agents, Local
Disinfectants
Chlorhexidine
Chlorhexidine gluconate

Additional relevant MeSH terms:
Anti-Infective Agents
Anti-Infective Agents, Local
Disinfectants
Chlorhexidine
Chlorhexidine gluconate
Therapeutic Uses
Infection
Dermatologic Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on May 07, 2009